Patient with two secondary somatic-type malignancies in a late recurrence of a testicular non-seminoma: Illustration of potential and flaw of the cancer stem cell therapy concept

International Journal of Developmental Biology

Volumn 57, Issue 2-4, 2013, Pages 153-157

  Oosterhuis, J Wolter ^a   Peeters, Suzanne H P ^b   Smit, Vincent T H B M ^b   Stoop, Hans ^a   Looijenga, Leendert H J ^a   Elzevier, Henk W ^b   Osanto, Suzanne ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Case report; Chemotherapy; Cisplatin; Residual mature teratora; Secondary non germ cell malignancy

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADENOCARCINOMA; ADULT; ARTICLE; BLOOD EXAMINATION; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STEM CELL; CANCER THERAPY; CASE REPORT; ECHOGRAPHY; EMBRYO PATTERN FORMATION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; LYMPH NODE METASTASIS; MALE; MEDICAL HISTORY; MULTIPLE CYCLE TREATMENT; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROPERITONEAL CANCER; SCROTAL SWELLING; TESTIS TUMOR; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; CELL- AND TISSUE-BASED THERAPY; HUMANS; INTESTINES; LEIOMYOSARCOMA; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, GERM CELL AND EMBRYONAL; NEOPLASTIC STEM CELLS; PROGNOSIS; TESTICULAR NEOPLASMS;

EID: 84880056383     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.130141jo     Document Type: Article

References (30)

1. ANDREWS, P.W., DAMJANOV, I., SIMON, D., BANTING, G.S., CARLIN, C., DRA-COPOLI, N.C. and FOGH, J. (1984). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Differentiation in vivo and in vitro. Lab Invest 50: 147-162.
2. BRABLETZ, T., JUNG, A., SPADERNA, S., HLUBEK, F. and KIRCHNER, T. (2005). Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5: 744-749.
3. CARVER, B.S., SHAYEGAN, B., SERIO, A., MOTZER, R.J., BOSL, G.J. and SHEINF-ELD, J. (2007). Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma. J Clin Oncol 25: 1033-1037.
4. COMITER, C.V., KIBEL, A.S., RICHIE, J.P., NUCCI, M.R. and RENSHAW, A.A. (1998). Prognostic features of teratomas with malignant transformation: a clinicopathologi-cal study of 21 cases. J Urol 159: 859-863.
5. DAMJANOV, I. (1990). Teratocarcinoma stem cells. Cancer Surv. 9: 303-320.
6. DEAN, M., FOJO, T. and BATES, S. (2005). Tumour stem cells and drug resistance. Nat Rev Cancer 5: 275-284.
7. FIDLER, I.J. (2003). The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458.
8. GANJOO, K.N., FOSTER, R.S., MICHAEL, H., DONOHUE, J.P. and EINHORN, L.H. (2001). Germ cell tumor associated primitive neuroectodermal tumors. J Urol 165: 1514-1516.
9. GUO, C.C., PUNAR, M., CONTRERAS, A.L., TU, S.M., PISTERS, L., TAMBOLI, P. and CZERNIAK, B. (2009). Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases. Am J Surg Pathol 33: 1173-1178.
10. HANAHAN, D. and WEINBERG, R.A. (2011). Hallmarks of cancer: the next genera-tion. Cell 144: 646-674.
11. IGCCC. (1997). International Germ Cell Consensus Classification: a prognostic fac-tor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group [see comments]. J Clin Oncol 15: 594-603.
12. KREGE, S., BEYER, J., SOUCHON, R., ALBERS, P., ALBRECHT, W., ALGABA, F., BAMBERG, M., BODROGI, I., BOKEMEYER, C., CAVALLIN-STAHL, E. et al., (2008). European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II. Eur Urol 53: 497-513.
13. LEVIN, M. (2012). Morphogenetic fields in embryogenesis, regeneration, and cancer: Non-local control of complex patterning. Biosystems 109: 243-261.
14. LOEHRER, P.J., HUI, S., CLARK, S., SEAL, M., EINHORN, L.H., WILLIAMS, S.D., ULBRIGHT, T.M., MANDELBAUM, I., ROWLAND, R.G. and DONOHUE, J.P. (1986). Teratoma following cisplatin-based combination chemotherapy for nonseminoma-tous germ cell tumors: a clinicopathological correlation. J.Urol. 135: 1183-1189.
15. LOOIJENGA, L.H.J., STOOP, H., DE LEEUW, P.J.C., DE GOUVEIA BRAZAO, C.A., GILLIS, A.J.M., VAN ROOZENDAAL, K.E.P., VAN ZOELEN, E.J.J., WEBER, R.F.A., WOLFFENBUTTEL, K.P., VAN DEKKEN, H. et al., (2003). POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63: 2244-2250.
16. MALAGON, H.D., VALDEZ, A.M., MORAN, C.A. and SUSTER, S. (2007). Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemi-cal study of 46 cases. Am J Surg Pathol 31: 1356-1362.
17. MAYER, F., STOOP, H., SCHEFFER, G.L., SCHEPER, R., OOSTERHUIS, J.W., LOOIJENGA, L.H. and BOKEMEYER, C. (2003). Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res 9: 767-773.
18. MICHAEL, H., HULL, M.T., ULBRIGHT, T.M., FOSTER, R.S. and MILLER, K.D. (1997). Primitive neuroectodermal tumors arising in testicular germ cell neoplasms. Am J Surg Pathol 21: 896-904.
19. MICHAEL, H., LUCIA, J., FOSTER, R.S. and ULBRIGHT, T.M. (2000). The pathology of late recurrence of testicular germ cell tumors. Am J Surg Pathol 24: 257-273.
20. MOLENAAR, W.M., OOSTERHUIS, J.W., MEIRING, A., SLEIJFER, D.T., SCHRAF-FORDT KOOPS, H. and CORNELISSE, C.J. (1986). Histology and DNA contents of a secondary malignancy arising in a mature residual lesion six years after chemotherapy for a disseminated onseminomatous testicular tumor. Cancer 58: 264-268.
21. MOTZER, R.J., AMSTERDAM, A., PRIETO, V., SHEINDELD, J., MURTY, V.V.V.S., MAZUMDAR, M., BOSL, G.J., CHAGANTI, R.S.K. and REUTER, V.E. (1998). Teratoma with malignant tansformation: diverse malignant histologies arising in men with germ cell tumors. J Urol 159: 133-138.
22. OOSTERHUIS, J.W. (1983). The metastasis of human teratomas. In The human teratomas, (ed. DAMJANOV, I.KNOWLES, B. and SOLTER, D.). Humana Press, Clifton, New Jersey, pp.137-171.
23. OOSTERHUIS, J.W., ANDREWS, P.W., KNOWLES, B.B. and DAMJANOV, I. (1984). Effects of cis-platinum on embryonal carcinoma cell lines in vitro. Int J Cancer 34: 133-139.
24. OOSTERHUIS, J.W., CASTEDO, S.M.M.J., DE JONG, B., CORNELISSE, C.J., DAM, A., SLEIJFER, D.T. and SCHRAFFORDT KOOPS, H. (1989). Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab Invest 60: 14-20.
25. PAPAIOANNOU, V.E. and ROSSANT, J. (1983). Effects of the embryonic environ-ment on proliferation and differentiation of embryonal carcinoma cells. Cancer Surv 2: 165-183.
26. REYA, T., MORRISON, S.J., CLARKE, M.F. and WEISSMAN, I.L. (2001). Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
27. ULBRIGHT, T.M., AMIN, M.B. and YOUNG, R.H. (1997). Tumors of the testis, adnexa, spermatic cord, and scrotum. AFIP, Washington.
28. ULBRIGHT, T.M., LOEHRER, P.J., ROTH, L.M., EINHORN, L.H., WILLIAMS, S.D. and CLARK, S.A. (1984). The development of non-germ cell malignancies within germ cell tumors. Cancer 54: 1824-1833.
29. WILAND, H.O., PAVLIDAKEY, P.G. and MACLENNAN, G.T. (2010). Nongerm cell malignancies in testicular germ cell tumors. J Urol 183: 327-328.
30. WOODWARD, P.J., HEIDENREICH, A., LOOIJENGA, L.H.J., OOSTERHUIS, J.W., MCLEOD, D.G. and MOLLER, H. (2004). Testicular germ cell tumors. In World Health Organization Classification of Tumours. Pathology and Genetics of the Urinary System and Male Genital Organs., (ed. EBLE, J. N.SAUTER, G.EPSTEIN, J. I. and SESTERHANN, I. A.). IARC Press, Lyon, pp.217-278.